Table 1A.
Clinicopathologic data of the breast cohort patients (N=108)
| Sex | |
| Female | 108 (100%) |
| Age (Mean/Range) | 54.05 (25-86) |
| Diagnosis Age | |
| <35 | 5 (4.63%) |
| 35-44 | 35 (32.41%) |
| 45-54 | 25 (23.15%) |
| 55-64 | 14 (12.96%) |
| ≥65 | 29 (26.85%) |
| Bilateral Breast | 18 (16.67%) |
| Personal cancers | |
| Breast Cancer only | 90 (83.33%) |
| Both Breast & Ovarian or GYN cancers | 3 (2.78%) |
| Breast cancer with multiple other cancers | 15 (13.89%) |
| Menopause | |
| Yes | 54 (50.00%) |
| Family History (1st or 2nd degree) | |
| Breast Cancer | 37 (34.26%) |
| Ovarian Cancer | 4 (3.70%) |
| BRCA Related Cancer (other than Breast & Ovarian) | 43 (39.81%) |
| Histology of Breast tumors | |
| Ductal | 82 (75.93%) |
| Ductal + Lobular/Medullary | 3 (2.78%) |
| In situ carcinoma | 7 (6.48%) |
| Lobular | 6 (5.56%) |
| Medullary | 1 (0.93%) |
| Others/Unclassified | 9 (8.33%) |
| Molecular Subtypes of Breast tumors | |
| Hormonal + | 75 (69.44%) |
| TNBC | 19 (17.59%) |
| Her2 | 14 (12.96%) |
| Stage | |
| Stage 0 | 7 (6.48%) |
| Stage I | 34 (31.48%) |
| Stage II | 51 (47.22%) |
| Stage III | 16 (14.81%) |
| Invasive Grade | |
| Grade 1 | 15 (15.46%) |
| Grade 2 | 49 (50.52%) |
| Grade 3 | 33 (34.02%) |
| Not stated | 4 |
| DCIS only | 7 |